Ozempic

Novo Nordisk A/S (NYSE:NVO) has reported that U.S. patients are staying on their Wegovy weight-loss medication for an average of six months. What Happened: Doug Langa, Novo’s head of North America operations, shared this information during a call with analysts following the company’s...

Shares of Novo Nordisk (NYSE:NVO), the pharmaceutical giant behind “miracle” weightloss drugs Ozempic and Wegovy, took a hit in pre-market trading on Wednesday, following the announcement of its second-quarter results, which fell short of expectations. The company also revised its...

NAD+ boosters are the new anti-aging trend in Hollywood, taking over from Ozempic and Botox in high-end wellness regimens. What Happened: Notable personalities like Hailey Bieber and the Kardashians, as well as wellness influencers, are adopting these supplements, which claim to replenish the body...

Novo Nordisk A/S. (NYSE:NVO) has found that its “miracle” weight loss drug used for diabetes, Ozempic, is linked to a significant reduction in the risk of dementia and other cognitive issues. What Happened: A study conducted at the University of Oxford revealed that patients who used...

Eli Lilly and Co. (NYSE:LLY) has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’s Mounjaro lost more weight than those on Novo Nordisk’s (NYSE:NVO) Ozempic. What Happened: The study, published on the JAMA Internal Medicine...

The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs, who shared this optimistic forecast in an exclusive interview with Benzinga. “Our view is that in the long term, this is not a two-horse race...

Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry’s, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent company Unilever plc‘s (NYSE:UL) ice cream division. What Happened: The duo, both 73,...

In a recent tweet, Bernie Sanders (I-Vt.) criticized the pricing of a popular diabetes drug, Ozempic, and its manufacturer, Novo Nordisk A/S (NYSE:NVO). What Happened: Sanders took to X, formerly Twitter, on Wednesday to express his concerns about the pricing of Ozempic. He suggested that the drug...

Novo Nordisk‘s (NYSE:NVO) weight loss drug Wegovy has received approval in China, representing a notable achievement for the Danish pharmaceutical firm. In response to this announcement, the company’s U.S.-listed stock is experiencing a surge of over 2% in pre-market trading on Tuesday...

Novo Nordisk A/S (NYSE:NVO) is set to invest $4.1 billion in expanding its U.S. manufacturing operations to meet the increasing demand for its weight loss drugs. What Happened: The Danish pharmaceutical company plans to build a new 1.4 million square foot manufacturing plant near Raleigh, North...

Gilead Sciences, Inc. (NASDAQ:GILD) witnessed a flurry of Wall Street speculation regarding its potential involvement in the obesity drug market. But, the biotech company, renowned for its cancer and HIV treatments, has not positioned itself as a contender in this lucrative field. Most recently,...

Danish biotech company Zealand Pharma A/S (OTC:ZLDPF) has announced encouraging topline results from a Phase 1b multiple ascending dose (MAD) trial of its weight management drug, petrelintide. The trial results were released on Thursday and comes at a time when the weightloss drug market is...

Americans love their pets: could the success of Novo Nordisk A/S (NYSE:NVO) drugs Ozempic and Wegovy and Eli Lilly And Co‘s (NYSE:LLY) Zepbound be a model for similar weight loss drugs in the pet market? What Happened: A recent Bloomberg newsletter outlined several recent developments in the...

U.S. District Judge Karen Marston in Philadelphia is set to preside over litigation involving the popular diabetes and weight-loss drugs Ozempic, Wegovy, and Mounjaro. The Judicial Panel on Multidistrict Litigation appointed Marston to manage over 10,000 personal injury lawsuits. U.S. District...

The rise of weight loss drugs like Wegovy and Mounjaro by Novo Nordisk (NYSE:NVO) is leading to new product developments across various sectors. What Happened: Companies from food and beverage to fitness are adapting to the increased demand for these drugs, hoping to capitalize on shifting consumer...